Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
Date:2/11/2010

230 Total assets 952,918 1,053,461 154,332 Liabilities Current liabilities Accounts payable 1,939 2,736 401 Deferred grant income 374 374 55 Accrued expenses and other payables 25,273 33,421 4,896 Income tax payable 1,256 1,914 280 Other current liabilities 57 -- -- Total current liabilities 28,899 38,445 5,632 Deferred grant income 3,152 2,778 407 Other liabilities 472 -- -- Total liabilities 32,523 41,223 6,039 Commitments and contingencies -- -- -- Shareholders' equity Share capital -ordinary shares US$0.0001 par value, 500,000,000 shares authorized, 150,575,955 and 150,641,461 issued and outstanding as of December 31, 2008 and 2009, respectively. 121 121 18 Additional paid-in capital 908,377 915,267 134,087 Accumulated other comprehensive loss (102,126) (100,608) (14,740) Retained earnings 114,023 197,458 28,928 To Total shareholders' equity 920,395 1,012,238 148,293 Total liabilities and shareholders' equity 952,918 1,053,461 154,332 Note: (1) Restricted cash balance represents cash bank balances as of December 31, 2009 that are temporarily restricted from use due to the incorporation process of Liaoning Sunshine Development Limited Company. The restriction will be removed once the incorporation process is completed. 3SBio Inc. and subsidiari
'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Pa. , July 25, 2014 /PRNewswire-iReach/ -- ... and consulting for global corporations operating in highly ... host its first annual Global User Group Conference, ... historic Philadelphia, Pennsylvania at ... - http://photos.prnewswire.com/prnh/20140724/130263 This ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)...  Now available is a stem cell therapy that ... , located in Guadalajara, Mexico , ... new health option: stem cell therapies for sports ... suffer from joint and muscle injuries due to professional ... rotator cuff, tennis elbow, and knee injuries. Throughout life ...
(Date:7/24/2014)... rely on sophisticated equipment, trained personnel, and detection ... against terrorist attacks. A revolutionary new electronic chip ... their job much easier. , The groundbreaking nanotechnology-inspired ... Aviv University ,s School of Chemistry and Center ... Herzliya company Tracense, picks up the scent of ...
Breaking Biology Technology:Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Nano-sized chip 'sniffs out' explosives far better than trained dogs 2
... a leading,provider of automated screening solutions for ... DPI, a contract research organization with,leading expertise ... utilize,Cellectricon,s Dynaflow(R)HT, a fully automated patch clamp ... capacity, particularly,for fast ligand-gated ion channels. , ...
... April 27 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (OTC ... of the leading plasma-based pharmaceutical companies in the ... Company received an order,from one of the largest ... valued at $5.3 million to be sold under ...
... -- China Medical,Technologies, Inc. (the "Company") (Nasdaq: ... that develops, manufactures and markets advanced,in-vitro diagnostic products, ... its Bladder Cancer FISH Probe (the "Probe") from ... the People,s Republic of China. , ...
Cached Biology Technology:Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery 2China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India 2China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India 3
(Date:7/25/2014)... wildfires have been raging this summer and some of the ... In this image collected by the Moderate Resolution Imaging ... a swath of smoke has descended over the Great Lakes ... is the fire image from July 23, 2014 (first image ... as it drifts off southeastward. In the image, it ...
(Date:7/25/2014)... Nearly 600 scientists from 25 countries and ... Meeting organized by the Genetics Society of America ... in Seattle. The conference will feature close to ... results on topics including gene expression and regulation, ... technologies, evolution, aging, and a variety of diseases. ...
(Date:7/25/2014)... of Adelaide has opened the way for the development of ... In Australia, annual barley production is second only to wheat ... of the most important diseases of barley. , Senior Research ... of special growths on the cell walls of barley plants ... , The research, by the ARC Centre of Excellence in ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2New hope for powdery mildew resistant barley 2
... abnormal blood lipids are independent risk factors for stroke. However, ... of stroke remains unclear. As reported in the Neural ... by Dr. Xiaoyong Sai and colleagues from Chinese PLA General ... year period from the Chinese PLA General Hospital, based on ...
... northward along the Atlantic coast of Florida for the last ... likely because cold snaps there are becoming a thing of ... ecologists the week of Dec. 30 in the Proceedings ... and unique illustration of the speed and scale on which ...
... , It,s taken nearly 200 years, but scientists in Arizona ... sex gradually and adaptively evolved in the honeybee. ... the mid-1800s by a Silesian monk named Johann Dzierson, according ... E. Page Jr. Dzierson was trying to understand how males ...
Cached Biology News:Mangroves expand north as Florida freezes decline 2Molecular evolution of genetic sex-determination switch in honeybees 2Molecular evolution of genetic sex-determination switch in honeybees 3